Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy

Evanguelos Xylinas; Michael Rink; Vitaly Margulis; Thomas Clozel; Richard K. Lee; Evi Comploj; Giacomo Novara; Jay D. Raman; Yair Lotan; Alon Weizer; Morgan Roupret; Armin Pycha; Douglas S. Scherr; Christian Seitz; Vincenzo Ficarra; Quoc Dien Trinh; Pierre I. Karakiewicz; Francesco Montorsi; Marc Zerbib; Shahrokh F. Shariat

doi:10.1111/j.1464-410X.2012.11649.x

Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy

Evanguelos Xylinas, Michael Rink, Vitaly Margulis, Thomas Clozel, Richard K. Lee, Evi Comploj, Giacomo Novara, Jay D. Raman, Yair Lotan, Alon Weizer, Morgan Roupret, Armin Pycha, Douglas S. Scherr, Christian Seitz, Vincenzo Ficarra, Quoc Dien Trinh, Pierre I. Karakiewicz, Francesco Montorsi, Marc Zerbib, Shahrokh F. Shariat

Research output: Contribution to journal › Article › peer-review

121 Scopus citations

Abstract

Objective To report (i) the estimated glomerular filtration rate (eGFR) changes in patients undergoing radical nephro-ureterectomy (RNU) for upper tract urothelial carcinoma (UTUC); (ii) the rate of change in eGFR in patients eligible for cisplatin-based chemotherapy; and (iii) the association of preoperative, postoperative and rate of change of renal function variables with survival outcomes. Patient and Methods We performed a retrospective analysis of 666 patients treated with RNU for UTUC at seven international institutions from 1994 to 2007. The eGFR was calculated at baseline and at 3-6 months (Modification of Diet in Renal Disease formula (MDRD) and Chronic Kidney Disease Epidemiology Collaboration formula (CKD-EP) equations). Results The median (interquartile range) eGFR decreased by 18.2 (8-12)% after RNU. A total of 37% of patients had a preoperative eGFR ≥ 60 mL/min/1.73 m², which decreased to 16% after RNU (P < 0.001); 72% of patients had a preoperative eGFR ≥ 45 mL/min/1.73 m², which decreased to 52% after RNU (P < 0.001). The distributions were similar when analyses were restricted to patients with locally advanced disease (pT3-pT4) and/or lymph node metastasis. Patients older than the median age of 70 years were more likely to have a decrease in eGFR after RNU (P < 0.001). None of the renal function variables was associated with clinical outcomes such as disease recurrence, cancer-specific and overall mortality; however, when analyses were restricted to patients who had no adjuvant chemotherapy and did not experience disease recurrence (n = 431), a preoperative eGFR ≥ 60 mL/min/1.73 m² (P = 0.03) and a postoperative eGFR ≥ 45 mL/min/1.73 m² (P = 0.04) were associated with better overall survival in univariable analyses. Conclusions In patients who had UTUC, eGFR was low and furthermore, it significantly decreased after RNU. Renal function did not affect cancer-specific outcomes after RNU.

Original language	English (US)
Pages (from-to)	453-461
Number of pages	9
Journal	BJU international
Volume	112
Issue number	4
DOIs	https://doi.org/10.1111/j.1464-410X.2012.11649.x
State	Published - Aug 2013

Keywords

chemotherapy
radical nephroureterectomy
renal function
upper tract urothelial carcinoma

ASJC Scopus subject areas

Urology

Access to Document

10.1111/j.1464-410X.2012.11649.x

Cite this

Xylinas, E., Rink, M., Margulis, V., Clozel, T., Lee, R. K., Comploj, E., Novara, G., Raman, J. D., Lotan, Y., Weizer, A., Roupret, M., Pycha, A., Scherr, D. S., Seitz, C., Ficarra, V., Trinh, Q. D., Karakiewicz, P. I., Montorsi, F., Zerbib, M., & Shariat, S. F. (2013). Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU international, 112(4), 453-461. https://doi.org/10.1111/j.1464-410X.2012.11649.x

Xylinas, E, Rink, M, Margulis, V, Clozel, T, Lee, RK, Comploj, E, Novara, G, Raman, JD, Lotan, Y, Weizer, A, Roupret, M, Pycha, A, Scherr, DS, Seitz, C, Ficarra, V, Trinh, QD, Karakiewicz, PI, Montorsi, F, Zerbib, M & Shariat, SF 2013, 'Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy', BJU international, vol. 112, no. 4, pp. 453-461. https://doi.org/10.1111/j.1464-410X.2012.11649.x

@article{55bf72b27f604b3aa4276ac3d9f16a52,

title = "Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy",

abstract = "Objective To report (i) the estimated glomerular filtration rate (eGFR) changes in patients undergoing radical nephro-ureterectomy (RNU) for upper tract urothelial carcinoma (UTUC); (ii) the rate of change in eGFR in patients eligible for cisplatin-based chemotherapy; and (iii) the association of preoperative, postoperative and rate of change of renal function variables with survival outcomes. Patient and Methods We performed a retrospective analysis of 666 patients treated with RNU for UTUC at seven international institutions from 1994 to 2007. The eGFR was calculated at baseline and at 3-6 months (Modification of Diet in Renal Disease formula (MDRD) and Chronic Kidney Disease Epidemiology Collaboration formula (CKD-EP) equations). Results The median (interquartile range) eGFR decreased by 18.2 (8-12)% after RNU. A total of 37% of patients had a preoperative eGFR ≥ 60 mL/min/1.73 m2, which decreased to 16% after RNU (P < 0.001); 72% of patients had a preoperative eGFR ≥ 45 mL/min/1.73 m2, which decreased to 52% after RNU (P < 0.001). The distributions were similar when analyses were restricted to patients with locally advanced disease (pT3-pT4) and/or lymph node metastasis. Patients older than the median age of 70 years were more likely to have a decrease in eGFR after RNU (P < 0.001). None of the renal function variables was associated with clinical outcomes such as disease recurrence, cancer-specific and overall mortality; however, when analyses were restricted to patients who had no adjuvant chemotherapy and did not experience disease recurrence (n = 431), a preoperative eGFR ≥ 60 mL/min/1.73 m2 (P = 0.03) and a postoperative eGFR ≥ 45 mL/min/1.73 m2 (P = 0.04) were associated with better overall survival in univariable analyses. Conclusions In patients who had UTUC, eGFR was low and furthermore, it significantly decreased after RNU. Renal function did not affect cancer-specific outcomes after RNU.",

keywords = "chemotherapy, radical nephroureterectomy, renal function, upper tract urothelial carcinoma",

author = "Evanguelos Xylinas and Michael Rink and Vitaly Margulis and Thomas Clozel and Lee, {Richard K.} and Evi Comploj and Giacomo Novara and Raman, {Jay D.} and Yair Lotan and Alon Weizer and Morgan Roupret and Armin Pycha and Scherr, {Douglas S.} and Christian Seitz and Vincenzo Ficarra and Trinh, {Quoc Dien} and Karakiewicz, {Pierre I.} and Francesco Montorsi and Marc Zerbib and Shariat, {Shahrokh F.}",

year = "2013",

month = aug,

doi = "10.1111/j.1464-410X.2012.11649.x",

language = "English (US)",

volume = "112",

pages = "453--461",

journal = "BJU international",

issn = "1464-4096",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy

AU - Xylinas, Evanguelos

AU - Rink, Michael

AU - Margulis, Vitaly

AU - Clozel, Thomas

AU - Lee, Richard K.

AU - Comploj, Evi

AU - Novara, Giacomo

AU - Raman, Jay D.

AU - Lotan, Yair

AU - Weizer, Alon

AU - Roupret, Morgan

AU - Pycha, Armin

AU - Scherr, Douglas S.

AU - Seitz, Christian

AU - Ficarra, Vincenzo

AU - Trinh, Quoc Dien

AU - Karakiewicz, Pierre I.

AU - Montorsi, Francesco

AU - Zerbib, Marc

AU - Shariat, Shahrokh F.

PY - 2013/8

Y1 - 2013/8

N2 - Objective To report (i) the estimated glomerular filtration rate (eGFR) changes in patients undergoing radical nephro-ureterectomy (RNU) for upper tract urothelial carcinoma (UTUC); (ii) the rate of change in eGFR in patients eligible for cisplatin-based chemotherapy; and (iii) the association of preoperative, postoperative and rate of change of renal function variables with survival outcomes. Patient and Methods We performed a retrospective analysis of 666 patients treated with RNU for UTUC at seven international institutions from 1994 to 2007. The eGFR was calculated at baseline and at 3-6 months (Modification of Diet in Renal Disease formula (MDRD) and Chronic Kidney Disease Epidemiology Collaboration formula (CKD-EP) equations). Results The median (interquartile range) eGFR decreased by 18.2 (8-12)% after RNU. A total of 37% of patients had a preoperative eGFR ≥ 60 mL/min/1.73 m2, which decreased to 16% after RNU (P < 0.001); 72% of patients had a preoperative eGFR ≥ 45 mL/min/1.73 m2, which decreased to 52% after RNU (P < 0.001). The distributions were similar when analyses were restricted to patients with locally advanced disease (pT3-pT4) and/or lymph node metastasis. Patients older than the median age of 70 years were more likely to have a decrease in eGFR after RNU (P < 0.001). None of the renal function variables was associated with clinical outcomes such as disease recurrence, cancer-specific and overall mortality; however, when analyses were restricted to patients who had no adjuvant chemotherapy and did not experience disease recurrence (n = 431), a preoperative eGFR ≥ 60 mL/min/1.73 m2 (P = 0.03) and a postoperative eGFR ≥ 45 mL/min/1.73 m2 (P = 0.04) were associated with better overall survival in univariable analyses. Conclusions In patients who had UTUC, eGFR was low and furthermore, it significantly decreased after RNU. Renal function did not affect cancer-specific outcomes after RNU.

AB - Objective To report (i) the estimated glomerular filtration rate (eGFR) changes in patients undergoing radical nephro-ureterectomy (RNU) for upper tract urothelial carcinoma (UTUC); (ii) the rate of change in eGFR in patients eligible for cisplatin-based chemotherapy; and (iii) the association of preoperative, postoperative and rate of change of renal function variables with survival outcomes. Patient and Methods We performed a retrospective analysis of 666 patients treated with RNU for UTUC at seven international institutions from 1994 to 2007. The eGFR was calculated at baseline and at 3-6 months (Modification of Diet in Renal Disease formula (MDRD) and Chronic Kidney Disease Epidemiology Collaboration formula (CKD-EP) equations). Results The median (interquartile range) eGFR decreased by 18.2 (8-12)% after RNU. A total of 37% of patients had a preoperative eGFR ≥ 60 mL/min/1.73 m2, which decreased to 16% after RNU (P < 0.001); 72% of patients had a preoperative eGFR ≥ 45 mL/min/1.73 m2, which decreased to 52% after RNU (P < 0.001). The distributions were similar when analyses were restricted to patients with locally advanced disease (pT3-pT4) and/or lymph node metastasis. Patients older than the median age of 70 years were more likely to have a decrease in eGFR after RNU (P < 0.001). None of the renal function variables was associated with clinical outcomes such as disease recurrence, cancer-specific and overall mortality; however, when analyses were restricted to patients who had no adjuvant chemotherapy and did not experience disease recurrence (n = 431), a preoperative eGFR ≥ 60 mL/min/1.73 m2 (P = 0.03) and a postoperative eGFR ≥ 45 mL/min/1.73 m2 (P = 0.04) were associated with better overall survival in univariable analyses. Conclusions In patients who had UTUC, eGFR was low and furthermore, it significantly decreased after RNU. Renal function did not affect cancer-specific outcomes after RNU.

KW - chemotherapy

KW - radical nephroureterectomy

KW - renal function

KW - upper tract urothelial carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84880829926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880829926&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2012.11649.x

DO - 10.1111/j.1464-410X.2012.11649.x

M3 - Article

C2 - 23464979

AN - SCOPUS:84880829926

SN - 1464-4096

VL - 112

SP - 453

EP - 461

JO - BJU international

JF - BJU international

IS - 4

ER -

Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this